The literature data supports the claim that supraphysiological T doses induce maladaptive cardiac hypertrophy [52] and that molecular mechanisms responsible for the deterioration of heart function include mTOR and ERK1/2 pathways, at least in part, which were also connected to oxidative stress production. Here, MAPK3 is linked to cardiac hypertrophy.